Suppression of tumorigenicity and metastasis of human renal carcinoma cells by infection with retroviral vectors harboring the murine inducible nitric oxide synthase gene

Human Gene Therapy

Volumn 9, Issue 6, 1998, Pages 845-854

  Juang, Shin Hun ^a   Xie, Keping ^a   Xu, Lei ^a   Shi, Qian ^a   Wang, Yunfang ^a   Yoneda, Junya ^a   Fidler, Isaiah J ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEOMYCIN; NITRIC OXIDE SYNTHASE; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; CANCER CELL CULTURE; CARCINOGENICITY; CONTROLLED STUDY; CYTOTOXICITY; GENE CONTROL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; KIDNEY CARCINOMA; LONG TERMINAL REPEAT; LUNG METASTASIS; MACROPHAGE; NONHUMAN; NUDE MOUSE; PROMOTER REGION; RETROVIRUS; SIMIAN VIRUS 40; SUPERNATANT;

ANIMALIA; MURINAE; MUS MUSCULUS; SIMIAE; SIMIAN VIRUS; SIMIAN VIRUS 40; UNIDENTIFIED RETROVIRUS;

EID: 0032503018     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.6-845     Document Type: Article

References (4)

1. ALBINA, J.E. (1995). On the expression of nitric oxide synthase by human macrophages: Why no NO? J. Leukocyte Biol. 58, 643-649.
2. ALBINA, J.E., CUI, S., MATEO, R.B., and REICHNER, J.S. (1993). Nitric oxide-mediated poptosis in murine peritoneal macrophages. J. Immunol. 150, 5080-5085.
3. AMBS, S., MERRIAN, W.G., BENNETT, W.P., OGUNFUSIKA, M., HUSSAIN, S.P., TZENG, E., GELLER, D.A., BILLIAR, T.R., and HARRIS, C.C. (1997). Interaction of nitric oxide and p53 in tumor growth: A putative model for clonal selection of mutant p53 gene. Proc. Am. Assoc. Cancer Res. 38, 273. [Abstract]
4. ZHANG, X., LAUBACH, V.E., ALLEY, E.W., EDWARDS, K.A., SHERMAN, P.A., RUSSELL, S.W., and MURPHY, W.J. (1996). Transcriptional basis for hyporesponsiveness of the human inducible nitric oxide synthase gene to lipopolysaccharide/interferon-gamma. J. Leukocyte Biol. 59, 575-585.